Key result
The combination of amiodarone and digitalis in a patient with acute non-ischemic ventricular dysfunction due to tachycardiomyopathy resulted in torsade de pointes.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Highlights potential torsade de pointes risk with amiodarone-digitalis in tachycardiomyopathy; leaves open confirmation in larger studies.
Amiodarone is one of the most used anti-arrhythmic drug for rate and rhythm control in atrial fibrillation. Unfortunately, it has also well-known pro-arrhythmic properties and it has been reported as a common cause of malignant ventricular tachyarrhytmias, especially torsade de pointes. Proarrhytmic effects of amiodarone are greatly increased by other concomitant factors, such as ventricular dysfunction and concomitant treatment with digitalis. Current evidence shows how amiodarone and digitalis together are associated with torsade de pointes in ischemic patients with heart failure. The present case report describes, for the first time, how amiodarone and digital can concur in producing torsade de pointes also in a tachycardiomyopathic patient with no coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Guerra et al. (2014) conducted a case report in Atrial fibrillation with tachycardiomyopathy (n=1). Amiodarone and digoxin was evaluated on Torsade de pointes. The combination of amiodarone and digitalis in a patient with acute non-ischemic ventricular dysfunction due to tachycardiomyopathy resulted in torsade de pointes.
Synapse has enriched 10 related papers. Consider them for comparative context: